Enteroparasitosis infections among renal transplant recipients in Khartoum state, Sudan 2012-2013

BMC Research Notes
Nouh Saad MohamedAli Mahmoud Mohammed Edris

Abstract

Renal transplantation procedure markedly increased over the past few decades. The risk of harboring parasitic diseases may affect transplant recipients during life expectancy. We aimed in this study to determine the enteroparasitosis frequency among renal transplant recipients in Khartoum state, Sudan. A case-control hospital-based study performed between November 2012 and May 2013, on 300 renal transplant recipients attending Sudanese Kidney Association hospital in Khartoum state, Sudan, along with 300 normal healthy individuals matching the case in age and sex. Stool samples were collected for parasitological studies. Out of the 300 renal transplant recipients: 242 (80.7%) were males mean age 43 ± 11.28 and 58 (19.3%) were females mean age 41 ± 13.41. Intestinal parasitic infection was observed in 118 participants and the overall frequency was 19.7%; of which 64 were cases (21.3%) and 54 (18.0%) were controls. Eight different species of intestinal parasites were identified; Entamoeba histolytica/dispar (7.5%), Entamoeba coli (6.5%), Giardia lambelia (3.2%), Cryptosporidium parvum (1.2%), Ascaris lumbricoides (0.6%), Enterobius vermicularis (0.3%), (0.2%) for each of Strongyloides stercoralis and Hymenolepis nana.

References

Mar 4, 1998·Tropical Medicine & International Health : TM & IH·G KangJ P Muliyil
Jul 15, 1998·Revista Da Sociedade Brasileira De Medicina Tropical·P P ChieffiP Jabur
Jul 4, 2001·QJM : Monthly Journal of the Association of Physicians·P R SánchezC R Olmos
Oct 31, 2001·Memórias do Instituto Oswaldo Cruz·M UlukanligilS Atay
Jan 17, 2004·Clinical Microbiology Reviews·Paul B Keiser, Thomas B Nutman
Nov 3, 2004·Transplantation Proceedings·N UdgiriN Malla
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Melanie Walker, Joseph R Zunt
Sep 27, 2005·Transplantation Proceedings·A I FiorelliS A Oliveira
Mar 7, 2006·European Journal of Epidemiology·R SpinelliP Dentico
Aug 31, 2006·Nature Clinical Practice. Nephrology·Rashad S Barsoum
Mar 17, 2007·Transplantation Proceedings·C ValarV D Garcia
Nov 21, 2008·Kidney International·Jon J SnyderBertram L Kasiske
Jan 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C N KottonUNKNOWN AST Infectious Diseases Community of Practice
Mar 2, 2011·Transplantation·Keith W HamiltonEmily A Blumberg
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·B S SchwartzUNKNOWN AST Infectious Diseases Community of Practice
Feb 26, 2014·Transplantation Research·Jeremy R Chapman
Feb 7, 2016·Asian Pacific Journal of Tropical Medicine·Omar Hassen AmerNajoua Al Sadok Haouas
Mar 13, 2016·Annals of Clinical Microbiology and Antimicrobials·Mona Ali MohamedAwad Ahmed Nasr

❮ Previous
Next ❯

Citations

Jul 29, 2019·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Mayra Ortega-DíazLaura Medina Zahonero

❮ Previous
Next ❯

Software Mentioned

Statistical Package for Social Sciences ( SPSS )

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Ascariasis

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.